Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117


[Increase in the incidence of invasive pneumococcal disease caused by serotype 19A prior to the implementation of the expanded pneumococcal vaccines].

González Martínez F, Saavedra Lozano J, Navarro Gómez ML, Santos Sebastián MM, Rodríguez Fernández R, González Sánchez M, Hernández-Sampelayo Matos T.

An Pediatr (Barc). 2013 Nov;79(5):288-92. doi: 10.1016/j.anpedi.2013.02.005. Epub 2013 Apr 13. Spanish.


[Emergence of invasive pneumococcal disease caused by non-vaccine serotypes in the era of the 7-valent conjugate vaccine].

González Martínez F, Navarro Gómez ML, Saavedra Lozano J, Santos Sebastián MM, Rodríguez Fernández R, González Sanchéz M, Cercenado Mansilla E, Hernández-Sampelayo Matos T.

An Pediatr (Barc). 2014 Mar;80(3):173-80. doi: 10.1016/j.anpedi.2013.05.003. Epub 2013 Jun 21. Spanish.


Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.

Techasaensiri C, Messina AF, Katz K, Ahmad N, Huang R, McCracken GH Jr.

Pediatr Infect Dis J. 2010 Apr;29(4):294-300. doi: 10.1097/INF.0b013e3181c2a229.


Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.

Hsu KK, Shea KM, Stevenson AE, Pelton SI; Massachusetts Department of Public Health.

Pediatr Infect Dis J. 2010 Apr;29(4):289-93. doi: 10.1097/INF.0b013e3181c15471.


Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.

Pai R, Moore MR, Pilishvili T, Gertz RE, Whitney CG, Beall B; Active Bacterial Core Surveillance Team.

J Infect Dis. 2005 Dec 1;192(11):1988-95. Epub 2005 Nov 1.


Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.

Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D, McCracken GH Jr.

Pediatr Infect Dis J. 2007 Jun;26(6):461-7.


Expansion of serotype coverage in the universal pediatric vaccination calendar: short-term effects on age- and serotype-dependent incidence of invasive pneumococcal clinical presentations in Madrid, Spain.

Picazo J, Ruiz-Contreras J, Casado-Flores J, Negreira S, García-de-Miguel MJ, Hernández-Sampelayo T, Otheo E, Méndez C; HERACLES Study Group.

Clin Vaccine Immunol. 2013 Oct;20(10):1524-30. doi: 10.1128/CVI.00239-13. Epub 2013 Aug 7.


The status of invasive pneumococcal disease among children younger than 5 years of age in north-west Lombardy, Italy.

Riva E, Salvini F, Garlaschi ML, Radaelli G, Giovannini M.

BMC Infect Dis. 2012 May 3;12:106. doi: 10.1186/1471-2334-12-106.


Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar.

Picazo J, Ruiz-Contreras J, Casado-Flores J, Giangaspro E, Del Castillo F, Hernández-Sampelayo T, Otheo E, Balboa F, Ríos E, Méndez C; Heracles Study Group.

Clin Vaccine Immunol. 2011 Jan;18(1):89-94. doi: 10.1128/CVI.00317-10. Epub 2010 Nov 3.


Evolving picture of invasive pneumococcal disease in massachusetts children: a comparison of disease in 2007-2009 with earlier periods.

Yildirim I, Stevenson A, Hsu KK, Pelton SI.

Pediatr Infect Dis J. 2012 Oct;31(10):1016-21. doi: 10.1097/INF.0b013e3182615615.


Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children.

van der Linden M, Reinert RR, Kern WV, Imöhl M.

BMC Infect Dis. 2013 Feb 5;13:70. doi: 10.1186/1471-2334-13-70.


Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.

Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, Reingold A, Thomas A, Schaffner W, Craig AS, Smith PJ, Beall BW, Whitney CG, Moore MR; Active Bacterial Core Surveillance/Emerging Infections Program Network.

J Infect Dis. 2010 Jan 1;201(1):32-41. doi: 10.1086/648593.


Capsular serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae causing invasive pneumococcal disease from 2009-2012 with an emphasis on serotype 19A in bacteraemic pneumonia and empyema and β-lactam resistance.

Lee MR, Chen CM, Chuang TY, Huang YT, Hsueh PR.

Int J Antimicrob Agents. 2013 Nov;42(5):395-402. doi: 10.1016/j.ijantimicag.2013.07.017. Epub 2013 Sep 6.


Incidence of pediatric invasive pneumococcal disease in the Island of Majorca (2008-2010), an area with non-universal vaccination, and estimations of serotype & children population coverage by available conjugate vaccines.

Picazo J, Dueñas J, Ramirez A, Perez AR, Padilla E, Herrero S, Gallegos C, Culebras E, Balseiro C, Mendez C.

BMC Infect Dis. 2013 Oct 29;13:503. doi: 10.1186/1471-2334-13-503.


Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.

Dagan R.

Clin Microbiol Infect. 2009 Apr;15 Suppl 3:16-20. doi: 10.1111/j.1469-0691.2009.02726.x. Review.


National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential.

Hsieh YC, Lin PY, Chiu CH, Huang YC, Chang KY, Liao CH, Chiu NC, Chuang YC, Chen PY, Chang SC, Liu JW, Yen MY, Wang JH, Liu CY, Lin TY.

Vaccine. 2009 Sep 4;27(40):5513-8. doi: 10.1016/j.vaccine.2009.06.091. Epub 2009 Jul 17.


Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.

Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R.

Pediatr Infect Dis J. 2009 Apr;28(4):277-82. doi: 10.1097/INF.0b013e31818e0e2e.


Supplemental Content

Support Center